Quantum Biopharma (QNTM) Change in Intangibles (2025 - 2026)
Quantum Biopharma (QNTM) posted Change in Intangibles of $68980.0 for Q1 2026, down 82.45% sequentially from $393004.0 in Q4 2025, and down 74.29% YoY from $268293.0 in Q1 2025.
Quantum Biopharma (QNTM) Change in Intangibles (2025 - 2026) Analysis & Trends
Quantum Biopharma has reported Change in Intangibles for 2 years, with the latest figure at $68980.0 in Q1 2026.
- Quarterly Change in Intangibles fell 74.29% year-over-year to $68980.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 757.69% YoY) and the FY2025 annual result came in at $2.5 million, changed N/A from the prior year.
- Change in Intangibles eased to $68980.0 in Q1 2026 per QNTM's latest filing, from $393004.0 in the prior quarter.
- Over five years, Change in Intangibles peaked at $1.8 million in Q3 2025 and troughed at $68980.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.68 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,980.00 |
| Mar 31, 2026 | 68,980.00 |
| Dec 31, 2025 | 393,004.00 |
| Dec 31, 2025 | 393,004.00 |
| Sep 30, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 85,720.00 |
| Jun 30, 2025 | 85,720.00 |
| Mar 31, 2025 | 268,293.00 |
| Mar 31, 2025 | 268,293.00 |